Literature DB >> 30720644

Antibiotic Prescription in Young Children With Respiratory Syncytial Virus-Associated Respiratory Failure and Associated Outcomes.

Steven L Shein1, Michele Kong2, Bryan McKee1, MaryAnn O'Riordan1, Philip Toltzis1, Adrienne G Randolph3,4.   

Abstract

OBJECTIVES: To describe antibiotic prescribing practices during the first 2 days of mechanical ventilation among previously healthy young children with respiratory syncytial virus-associated lower respiratory tract infection and evaluate associations between the prescription of antibiotics at onset of mechanical ventilation with clinical outcomes.
DESIGN: Retrospective cohort study.
SETTING: Forty-six children's hospitals in the United States. PATIENTS: Children less than 2 years old discharged between 2012 and 2016 with an International Classification of Diseases diagnosis of respiratory syncytial virus-associated lower respiratory tract infection, no identified comorbid conditions, and receipt of mechanical ventilation.
INTERVENTIONS: Antibiotic prescription during the first 2 days of mechanical ventilation.
MEASUREMENTS AND MAIN RESULTS: We compared duration of mechanical ventilation and hospital length of stay between children prescribed antibiotics on both of the first 2 days of mechanical ventilation and children not prescribed antibiotics during the first 2 days of mechanical ventilation. We included 2,107 PICU children with respiratory syncytial virus-associated lower respiratory tract infection (60% male, median age of 1 mo [interquartile range, 1-4 mo]). The overall proportion of antibiotic prescription on both of the first 2 days of mechanical ventilation was 82%, decreasing over the study period (p = 0.004) and varying from 36% to 100% across centers. In the bivariate analysis, antibiotic prescription was associated with a shorter duration of mechanical ventilation (6 d [4-9 d] vs 8 d [6-11 d]; p < 0.001) and a shorter hospital length of stay (11 d [8-16 d] vs 13 d [10-18 d]; p < 0.001). After adjustment for center, demographics, and vasoactive medication prescription, antibiotic prescription was associated with a 1.21-day shorter duration of mechanical ventilation and a 2.07-day shorter length of stay. Ultimately, 95% of children were prescribed antibiotics sometime during hospitalization, but timing, duration, and antibiotic choice varied markedly.
CONCLUSIONS: Although highly variable across centers and decreasing over time, the practice of instituting antibiotics after intubation in young children with respiratory syncytial virus-associated lower respiratory tract infection was associated with a shortened clinical course after adjustment for the limited available covariates. A prudent approach to identify and optimally treat bacterial coinfection is needed.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30720644     DOI: 10.1097/PCC.0000000000001839

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  4 in total

1.  Airway Bacterial Colonization, Biofilms and Blooms, and Acute Respiratory Infection.

Authors:  Mollie G Wasserman; Robert J Graham; Jonathan M Mansbach
Journal:  Pediatr Crit Care Med       Date:  2022-06-29       Impact factor: 3.971

2.  Nasopharyngeal Codetection of Haemophilus influenzae and Streptococcus pneumoniae Shapes Respiratory Syncytial Virus Disease Outcomes in Children.

Authors:  Alejandro Diaz-Diaz; Eleonora Bunsow; Cristina Garcia-Maurino; Melissa Moore-Clingenpeel; Jeffrey Naples; Alexis Juergensen; Sara Mertz; Huanyu Wang; Amy L Leber; James Gern; Mark W Hall; Daniel M Cohen; Octavio Ramilo; Asuncion Mejias
Journal:  J Infect Dis       Date:  2022-03-02       Impact factor: 7.759

3.  Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill children.

Authors:  Yarmarly C Guerra Valero; Tavey Dorofaeff; Jason A Roberts; Jeffrey Lipman; Mark G Coulthard; Louise Sparkes; Steven C Wallis; Suzanne L Parker
Journal:  Anal Bioanal Chem       Date:  2021-05-26       Impact factor: 4.142

4.  Optimal dosing of cefotaxime and desacetylcefotaxime for critically ill paediatric patients. Can we use microsampling?

Authors:  Yarmarly C Guerra Valero; Tavey Dorofaeff; Mark G Coulthard; Louise Sparkes; Jeffrey Lipman; Steven C Wallis; Jason A Roberts; Suzanne L Parker
Journal:  J Antimicrob Chemother       Date:  2022-07-28       Impact factor: 5.758

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.